Veru (VERU) Receivables (2009 - 2024)
Veru (VERU) recorded Receivables of $3.96 million in fiscal Q4 2024 (quarter ended Sep 30, 2024), down 12.1% from $4.51 million a year earlier but up 141.2% from the prior quarter.
Veru (VERU) Receivables (2009 - 2024) Analysis & Trends
Starting with fiscal Q4 2010, Veru's Receivables history includes 55 quarters.
- Annual Receivables has a five-year compound annual growth rate of -4.6% (FY2019 to FY2024).
- Across earlier fiscal years, Receivables came in at $4.51 million in FY2023 (+26.9%), $3.55 million in FY2022 (-59.6%), $8.79 million in FY2021 (+68.2%) and $5.23 million in FY2020 (+4.1%).
- Quarterly Receivables has ranged from $1.64 million in fiscal Q3 2024 to $13.31 million in fiscal Q3 2021 over the past five years.
- On a year-over-year basis, Receivables has declined for four consecutive quarters, with an average decline of 33.0% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 221.2% in fiscal Q3 2021, against a decline of 67.7% in fiscal Q3 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $1.64 million (Q3 2024), $2.79 million (Q2 2024) and $2.38 million (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Veru | 48.87 Mn | -61.41 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 3.96 Mn |
| Sep 30, 2024 | 3.96 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 2.79 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2023 | 5.08 Mn |
| Mar 31, 2023 | 4.21 Mn |
| Dec 31, 2022 | 3.86 Mn |
| Sep 30, 2022 | 3.55 Mn |
| Jun 30, 2022 | 8.30 Mn |
| Mar 31, 2022 | 8.13 Mn |
| Dec 31, 2021 | 8.07 Mn |
| Sep 30, 2021 | 8.79 Mn |
| Jun 30, 2021 | 13.31 Mn |
| Mar 31, 2021 | 7.65 Mn |
| Dec 31, 2020 | 6.66 Mn |
| Sep 30, 2020 | 5.23 Mn |
| Jun 30, 2020 | 4.14 Mn |
| Mar 31, 2020 | 5.80 Mn |
Veru Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=VERU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();